Dr. Nuria Alegret Ramon


Dr. Nuria Alegret Ramon

Centro Joxe Mari Korta
Avenida de Tolosa, 72
20018 Donostia-San Sebastián

email: nuria.alegret@ehu.eus
Tel:34 943 018018


Dr. Núria Alegret obtained her BS in Chemistry, MS in Computational Chemistry (2010) and MS in Nanoscience and Nanotechnology (2012) from the University Rovira i Virgili (URV). She has performed her PhD titled "Computations on Fullerenes: Finding Rules, Identifying Products and Disclosing Reaction Paths" in Computational and Experimental Chemistry of Fullerene Nanostructures, under the supervision of Prof. Josep M. Poblet (URV). Most of her projects during that period have been developed in collaboration with the leading scientists in the field of fullerenes, as Prof. Echegoyen and Prof. L. Balch. With them, Núria has defined the rules of formation of fullerenes, become an expert of the reactivity of fullerenes, and, among her achievements, she has determined that the most used reaction in fullerenes (Bingel-Hirsch) is kinetically controlled. Furthermore, she spent 8 months in Prof. Echegoyen's lab to improve her skills in experimental organic chemistry of fullerenes.  She obtained her Ph.D. degree in 2014, and she was awarded the Excellence Recognition.


In 2015, Núria moved to the Univeristy of Trieste (Italy) to work with Prof. Maurizio Prato as a post-doctoral researcher. In 2016, she was transferred to the second laboratory of Prof. Prato in the CIC BiomaGune center in San Sebastian (Spain), where she spent two years. Her research during these three years focused on the design and synthesis of CNT-based 3D scaffolds for nerve and cardiac tissue engineering.

In 2017, she was awarded a Global Marie Curie Fellowship between Polymat and the University of Colorado Denver (USA), to further expand her knowledge in a biological laboratory. Thus, in 2018 she moved to Prof. Luisa Mestroni group (UC Denver) where she is currently performing in vitro studies and expanding her knowledge and skills in the biomedical application of 3D CNT-based scaffolds for cardiac tissue engineering. After two years, she will return to Polymat to develop new kind of scaffolds and polymers, and evaluate them as electroactive tissue regeneration devices.

Innovative Polymers Group